GE HealthCare Technologies stock

GEHC · NASDAQ · USD

Compare GE HealthCare Technologies
$81.84Change from previous close: −1.35%Absolute change: −$1.12

Close · November 17, 2026

Price history

+17.12% over the period

1 year: from $70.63 (November 17, 2025) to $82.73 (November 17, 2026), +17.12%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 17, 2026$82.73
October 30, 2026$76.57
September 30, 2026$65.37
August 31, 2026$71.23
July 31, 2026$68.02
June 30, 2026$64.01
May 29, 2026$62.34
April 30, 2026$60.84
March 31, 2026$71.18
February 27, 2026$84.27
January 30, 2026$78.97
December 31, 2025$82.02
November 28, 2025$79.99
November 17, 2025$70.63

At a glance

  • The company

    Develop and market medical imaging systems, patient monitoring devices, diagnostic solutions and digital healthcare products

  • Latest results

    Quarter to September 30, 2026 · EPS $1.36 (estimate $1.31)

TickerLandia's take on GE HealthCare Technologies

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$58.75
52-wk high$89.77

−8.83% from the 52-week high

Analysts · 22 analysts

Average target$87.85+7.34% vs. price

Buy 15 · Hold 7 · Sell 0 · Buy

TickerLandia Fingerprint: GE HealthCare Technologies

Compared with similar companies: very low dividend and very strong momentum.

Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

GE HealthCare Technologies is priced as in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), GE HealthCare Technologies's P/E today is 18.2, in line with the median of its last 4 fiscal years (18.0; between 14.0 and 25.4 from 2022 to 2025). GE HealthCare Technologies's P/E (trailing 12 months): 17.3, −38% against the median of a group of 10 similar companies (28.1).

P/E compared with its history

Compared with 10 similar companies

GE HealthCare Technologies's metrics compared with similar companies
MetricGE HealthCare TechnologiesPosition in the groupBand
P/E (trailing 12 months)17.3Low
Forward P/E14.9Low
Operating margin13.8%Low
ROE20.0%High
Debt/equity0.88High

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: GE HealthCare Technologies. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$5.51B

Latest quarter · Q3 2026

Net income

$615M

Latest quarter · Q3 2026

Quarterly net margin

11.2%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$37B
P/E
17.3
EPS
$4.73
Volume
2.86M
Daily trading
€313.44M
Dividend yield
0.18%
Last ex-dividend on October 23, 2026

How GE HealthCare Technologies is changing

All results
  • Revenue grew 3.7% a year on average over the last 5 years

  • Operating margin rose from 13.5% to 14.9%

  • Free cash flow equal to 87% of net income

Returns

GE HealthCare Technologies returns with dividends

$1,000 invested in GE HealthCare Technologies 3 years ago, on November 17, 2023, would be worth $1,139 today with dividends reinvested: +13.93% in total, +4.44% per year. On price alone it would be $1,133 (+13.32%).

PeriodGE HealthCare TechnologiesS&P 500$1,000 becomes
1 month+18.59%−3.17%$1,186
6 months+34.69%+0.11%$1,347
Year to date+0.86%+8.34%$1,009
1 year+17.36%+11.15%$1,174
3 years+13.93%+64.30%$1,139

Over the last 6 months it has done better than 72% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

GE HealthCare Technologies: technical analysis

GE HealthCare Technologies shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 12.8% below its all-time closing high ($93.87, March 8, 2024).

Trend
No clear trend
RSI (14 sessions)
63
Between 30 and 70
vs 200-session average
+16.98%

Active signals

  • Golden cross: the 50-session average has crossed above the 200-session average.

    since November 11, 2026

Support and resistance

Price areas where GE HealthCare Technologies has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$87.34+6.72%2 touches, last on November 4, 2026
  2. Resistance$85.87+4.92%2 touches, last on February 4, 2026
  3. Last price$81.84
  4. Support$77.99−4.70%2 touches, last on January 29, 2026
  5. Support$76.09−7.03%3 touches, last on August 20, 2026
  6. Support$68.88−15.84%3 touches, last on March 30, 2026

Volatility and risk

Over the last year it has moved less than the S&P 500.

Beta (1 year) vs S&P 500
0.64
Volatility (60 sessions, annualised)
29.8%
Largest fall in the last year
−32.53%

Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

The company

GE HealthCare Technologies and its competitors

Sales outside the United States and China accounted for 45.7% of revenue in the fiscal year ended December 2025, while the United States accounted for 44.5% and China for 9.8%. The company develops, manufactures and sells equipment and digital software used to diagnose, treat and monitor patients. Its Imaging unit covers molecular imaging, CT, MR and X-ray systems, while its ultrasound and surgical visualization offerings serve areas such as cardiology and women's health.

Headquarters
Chicago, United States
Employees
54,000
Founded
1892
Chief executive
Peter Arduini
GE HealthCare Technologies and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
GE HealthCare TechnologiesGEHC$37B13.8%17.3+34.69%
DexComDXCM$30.44B24.0%32.1+33.12%
SterisSTE$25B19.2%30.5+21.36%
Edwards LifesciencesEW$61.59B28.8%61.6+29.55%
Boston ScientificBSX$63.33B19.6%18.4−18.32%
Zimmer Biomet HoldingsZBH$19.19B16.7%25.6+21.97%

Same industry or related industries, similar size. Compare GE HealthCare Technologies with its competitors · Full profile